The regulator's latest study will use eye-tracking tools.
Its "Beauty is Bone Deep" campaign looks at beauty from the inside.
Our year-end list captures the 10 that sparked heaviest interest.
Famous from his reality show, "The Osbournes," Jack narrates his life with MS in a web documentary series.
Regulators say the company has not received approval for the device's touted functions.
The company says it will cut staff and costs, focus on big accounts and try to keep sales reps from leaving.
The regulator will study how teens perceive ads and if targeted media needs unique standards.
The prostate cancer drug company is reportedly seeking a buyer to turn things around.
A Credit Suisse analyst notes that the company will need to make a significant impact to meet even lowered expectations. A possible fix: more sales reps behind Belviq.
23andMe aired its first TV ad Monday, in a bid to build the audience for DNA sequencing.
The Wizards of White Oak are spending $10 million on DTC ad research. Is this a wise use of sparse agency resources?
Marketing partner Transcept pulled 90 sales reps and Purdue closed out the majority of its DTC outreach in March.
Among social media channels, healthcare execs are most comfortable with YouTube and least comfortable with Twitter, a survey suggests.
The new survey will study whether patients understand how efficacy is calculated and experiment with ways to make communications clearer.
The FDA wants to know how physician attitudes towards direct-to-consumer advertising have evolved since the agency last asked them, in 2002. If a snap poll by CMI/Compas is any indication, drug companies probably won't like the answers.
Genzyme is taking rare disease awareness to another level with a documentary film, dubbed "Facing Fabry Together," that follows four families grappling with the genetic disorder.
Lilly said sales-force downsizing was the right move considering the current portfolio mix and generics shadow. Management also teased some vague pipeline details.
The agency is revisiting the impact DTC advertising can have on healthcare. What's new: NPs and PAs are being asked for input.
FDA's Office of Prescription Drug Promotion is taking an integrated approach to reviewing promotional materials and shedding its consumer- and professional-directed silos.
Pharma pared back its ad spend in 2012, a baby born HIV-positive is virus-free two-and-a-half years later, and Boston Children's Hospital is making its own apps.
PhRMA issued a terse response to a study claiming that ED drug advertisers more or less ignored the trade group's Guiding Principles for Direct to Consumer ads, a self-policing regime implemented in 2005 to fend off talk of a ban on drug ads.
A comprehensive survey of the scientific literature on direct-to-consumer advertising of prescription drugs reads more like the industry's case for DTC than you might expect—with a few big caveats.
The Leukemia & Lymphoma Society is looking to raise its profile—and donations—with its first-ever large-scale ad campaign.
After several years of quiet among prescription sleep aids, Purdue Pharma has issued a wake up call to the category with an ad campaign featuring an adorably memorable anthropomorphic lightbulb.
A Merck study bolsters FDA's case for requiring that TV ads for prescription drugs present risks in text as well as the voiceover.
Facing lower-than-expected demand, Purdue and Transcept are broadening the commercial strategy for Intermezzo to include DTC and a larger selling force.
Sanofi has recruited actress Elizabeth Perkins, who has type 1 diabetes, to serve as the face of its Diabetes Co-Stars awareness campaign.
Sales of Amgen's Prolia are set to rise after a "soft" quarter, thanks to a sales force overhaul and an impending return to TV advertising, the company said in a third quarter results call.
Sanofi Pasteur has launched its first consumer advertising for Fluzone Intradermal, featuring a prickly pitch-critter meant to stress the flu vaccine's extra-thin needle.
Google's latest data shows that the doctor-patient information divide isn't so much a divide as two parts of the same conversation.